A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients

Background. Dengue is the most common arboviral infection of humans. There are currently no specific treatments for dengue. Balapiravir is a prodrug of a nucleoside analogue (called R1479) and an inhibitor of hepatitis C virus replication in vivo. Methods. We conducted in vitro experiments to determ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 2013-05, Vol.207 (9), p.1442-1450
Hauptverfasser: Nguyen, Nguyet Minh, Tran, Chau Nguyen Bich, Phung, Lam Khanh, Duong, Kien Thi Hue, le Anh Huynh, Huy, Farrar, Jeremy, Nguyen, Quyen Than Ha, Tran, Hien Tinh, Van Vinh Nguyen, Chau, Merson, Laura, Hoang, Long Truong, Hibberd, Martin L., Aw, Pauline P. K., Wilm, Andreas, Nagarajan, Niranjan, Nguyen, Dung Thi, Pham, Mai Phuong, Nguyen, Truong Thanh, Javanbakht, Hassan, Klumpp, Klaus, Hammond, Janet, Petric, Rosemary, Wolbers, Marcel, Nguyen, Chinh Tran, Simmons, Cameron P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background. Dengue is the most common arboviral infection of humans. There are currently no specific treatments for dengue. Balapiravir is a prodrug of a nucleoside analogue (called R1479) and an inhibitor of hepatitis C virus replication in vivo. Methods. We conducted in vitro experiments to determine the potency of balapiravir against dengue viruses and then an exploratory, dose-escalating, randomized placebo-controlled trial in adult male patients with dengue with
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/jis470